Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Speaker announcement
: First Lady Jill Biden to Speak at Fierce JPM Week on January 14th
Keytruda
Pharma
GSK trial result mirrors Merck's problem in ovarian cancer
Merck's and GSK's similar overall survival setbacks suggest that PD-1 inhibitors may not be for ovarian cancer after all.
Angus Liu
Dec 20, 2024 10:46am
Keytruda-Lynparza combo scores tepid win in ovarian cancer trial
Dec 9, 2024 11:18am
Agenus to offer CDMO services, lay off staffers in latest reorg
Dec 5, 2024 7:51am
Merck moves a step closer with subcutaneous version of Keytruda
Nov 19, 2024 10:20am
Gardasil's troubles in China haunt Merck in Q3
Oct 31, 2024 1:25pm
Anyone with lungs can get cancer, warns new campaign
Oct 23, 2024 12:46pm
